1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Comparison by Application: (2022-2028)
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2028
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2028
1.4.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites, Area Served, Product Type
2.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
2.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue
2.5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario by Region
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Region
3.5.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
3.5.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.6.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.6.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
3.7.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Analysis by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2022)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2022)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022)
5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historic Market Analysis by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2022)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2022)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Ecotrin
6.2.1 Ecotrin Corporation Information
6.2.2 Ecotrin Description and Business Overview
6.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.2.5 Ecotrin Recent Developments/Updates
6.3 Generic
6.3.1 Generic Corporation Information
6.3.2 Generic Description and Business Overview
6.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.3.5 Generic Recent Developments/Updates
6.4 St. Joseph
6.4.1 St. Joseph Corporation Information
6.4.2 St. Joseph Description and Business Overview
6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.4.5 St. Joseph Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Merial
6.8.1 Merial Corporation Information
6.8.2 Merial Description and Business Overview
6.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.8.5 Merial Recent Developments/Updates
6.9 Merck Animal Health
6.9.1 Merck Animal Health Corporation Information
6.9.2 Merck Animal Health Description and Business Overview
6.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.9.5 Merck Animal Health Recent Developments/Updates
7 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)
7.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
8.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
9 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Dynamics
9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
9.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
9.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
9.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
10 Global Market Forecast
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2023-2028)
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2023-2028)
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
